Double Bond Pharmaceutical Competitors and Similar CompaniesClear all
Double Bond Pharmaceutical's competitors and similar companies include Turning Point Therapeutics.
 Double Bond Pharmaceutical Double Bond Pharmaceutical is a company that develops approaches for treatment of cancers. |  Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2013 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Uppsala, SE HQ Uppsala, SE | Locations San Diego, US HQ |
Employees | Employees 1318% increase | Employees 474% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) kr84k (FY, 2025) | Revenue (est.) $30.8m (FY, 2021) |
Net income | Net income (kr333k) (FY, 2025) | Net income ($236.6m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 81.7k | Total funding raised $ 144.4m |
For sources of this data, please see the company profile
View Company Profiles
Turning Point Therapeutics
HQ
San Diego, US
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
View company